Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United Kingdom

 

“Pens down” on UK deals before election

From psychiatric provider Priory Group, to nursing home group Four Seasons and PE-backed homecare company City & County Healthcare, HBI hears UK deals are off the cards until political certainty can be restored. We speak to advisers and enquire on the status of deals that could go ahead in the new year.

IDH looks set to sell next year – but could it sell even sooner?

There was speculation over the summer that the UK's biggest dental player by revenue, Mydentist (rebranded from IDH) was set to sell - and then all went quiet, drowned out in part by noise about Brexit and a possible election. But a sale is definitely on the cards next year and HBI hears rumours that investor Carlyle has been tentatively seeking earlier suitors for an accelerated exclusive bilateral deal before Christmas - though sources close to the company dismiss this suggestion out of hand.

Barchester to buy Four Seasons’ “jewel in the crown”

UK nursing home operator Barchester is reportedly in advanced talks to acquire 24 brighterkind homes, which were Four Seasons "jewel in the crown" before being carved off by owner Terra Firma. HBI considers the likely price and talks to a well-placed source to find out more.

Exclusive: SpaMedica pulled from sale as UK election and Brexit loom

The largest UK NHS cataract surgery provider, ophthalmic specialist SpaMedica, was pulled from sale recently after just a few weeks on the market and before bids could be submitted, HBI hears. But it could soon be back on the market, and HBI talks to three market experts to find out more about the aborted process, possible prices and suitors.

Exclusive: We name strategic buyer in talks to acquire BMI Healthcare

Independent sources tell HBI that UK hospital chain BMI Healthcare could soon be sold to another hospital operator by its landlord-turned-majority shareholder, just a year after it took over the business. We reveal the likely buyer, give the reaction of advisors and investors, and adjust BMI's likelihood of an imminent sale on HBI Intelligence Deals Pipeline tool to 95%.

Find Us